283 related articles for article (PubMed ID: 29098964)
1. Misdiagnosis of Graves' hyperthyroidism due to therapeutic biotin intervention.
De Roeck Y; Philipse E; Twickler TB; Van Gaal L
Acta Clin Belg; 2018 Oct; 73(5):372-376. PubMed ID: 29098964
[TBL] [Abstract][Full Text] [Related]
2. [Thyroid hormone changes in women with pre-eclampsia and its relationship with the presence of pre-eclampsia].
Zhou J; Du J; Ma B; Liu X; Qiu H; Li J; Wang X
Zhonghua Fu Chan Ke Za Zhi; 2014 Feb; 49(2):109-13. PubMed ID: 24739642
[TBL] [Abstract][Full Text] [Related]
3. Apparent Hyperthyroidism Caused by Biotin-Like Interference from IgM Anti-Streptavidin Antibodies.
Lam L; Bagg W; Smith G; Chiu WW; Middleditch MJ; Lim JC; Kyle CV
Thyroid; 2018 Aug; 28(8):1063-1067. PubMed ID: 29808739
[TBL] [Abstract][Full Text] [Related]
4. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
Izumi Y; Hidaka Y; Tada H; Takano T; Kashiwai T; Tatsumi KI; Ichihara K; Amino N
Clin Endocrinol (Oxf); 2002 Jul; 57(1):51-8. PubMed ID: 12100069
[TBL] [Abstract][Full Text] [Related]
5. [Apparent thyrotoxicosis in a patient with multiple sclerosis: biochemical assay interference due to high dose biotin use].
van den Berg R; Slim CL; Lutgers HL; de Heide LJM; Wolthuis A
Ned Tijdschr Geneeskd; 2018 Feb; 162():. PubMed ID: 30730120
[TBL] [Abstract][Full Text] [Related]
6. Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves' disease: a case report.
Shimmaru K; Inami M; Hamaoka A; Fujiwara N; Morioka T; Emoto M; Kamei N
Endocr J; 2023 Aug; 70(8):833-837. PubMed ID: 37331797
[TBL] [Abstract][Full Text] [Related]
7. Misdiagnosis of Graves' Disease with Apparent Severe Hyperthyroidism in a Patient Taking Biotin Megadoses.
Barbesino G
Thyroid; 2016 Jun; 26(6):860-3. PubMed ID: 27043844
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between thyroid hormones and renal function in severe pre-eclampsia patients with hypothyroidism].
Zhou J; Li W; Du J; Qiao C; Shang T; Liu X
Zhonghua Fu Chan Ke Za Zhi; 2014 Nov; 49(11):811-5. PubMed ID: 25603904
[TBL] [Abstract][Full Text] [Related]
9. [Effects of various contraceptives on laboratory parameters in diagnosis of thyroid gland function with special reference to the free hormones FT4 and FT3].
Sorger D; Schenk S; Schneider G
Z Gesamte Inn Med; 1992 Feb; 47(2):58-64. PubMed ID: 1585690
[TBL] [Abstract][Full Text] [Related]
10. Immunoassay design and biotin interference.
Dasgupta A
Adv Clin Chem; 2022; 109():165-183. PubMed ID: 35953126
[TBL] [Abstract][Full Text] [Related]
11. The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic.
Ross DS; Daniels GH; Gouveia D
J Clin Endocrinol Metab; 1990 Sep; 71(3):764-9. PubMed ID: 2394778
[TBL] [Abstract][Full Text] [Related]
12. Significant cardiac disease complicating Graves' disease in previously healthy young adults.
Witczak JK; Ubaysekara N; Ravindran R; Rice S; Yousef Z; Premawardhana LD
Endocrinol Diabetes Metab Case Rep; 2020 Jan; 2020():. PubMed ID: 31967967
[TBL] [Abstract][Full Text] [Related]
13. Best practices in mitigating the risk of biotin interference with laboratory testing.
Bowen R; Benavides R; Colón-Franco JM; Katzman BM; Muthukumar A; Sadrzadeh H; Straseski J; Klause U; Tran N
Clin Biochem; 2019 Dec; 74():1-11. PubMed ID: 31473202
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
Ide A; Amino N; Kang S; Yoshioka W; Kudo T; Nishihara E; Ito M; Nakamura H; Miyauchi A
Thyroid; 2014 Jun; 24(6):1027-31. PubMed ID: 24400892
[TBL] [Abstract][Full Text] [Related]
15. Hyperthyroidism in Patients with Graves' Ophthalmopathy, and Thyroidal, Skeletal and Eye Muscle Specific Type 2 Deiodinase Enzyme Activities.
Molnár I; Szentmiklósi JA; Somogyiné-Vári É
Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):514-521. PubMed ID: 28750432
[TBL] [Abstract][Full Text] [Related]
16. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference.
Piketty ML; Prie D; Sedel F; Bernard D; Hercend C; Chanson P; Souberbielle JC
Clin Chem Lab Med; 2017 May; 55(6):817-825. PubMed ID: 28222020
[TBL] [Abstract][Full Text] [Related]
17. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
18. [Intake of high dose biotin: A cause of artificial hyperthyroidism].
Bouillet B; Rouland A
Rev Med Interne; 2020 Feb; 41(2):123-125. PubMed ID: 31813616
[TBL] [Abstract][Full Text] [Related]
19. Biotin interference in immunoassays mimicking subclinical Graves' disease and hyperestrogenism: a case series.
Batista MC; Ferreira CES; Faulhaber ACL; Hidal JT; Lottenberg SA; Mangueira CLP
Clin Chem Lab Med; 2017 May; 55(6):e99-e103. PubMed ID: 27718482
[No Abstract] [Full Text] [Related]
20. Factitious Graves' Disease Due to Biotin Immunoassay Interference-A Case and Review of the Literature.
Elston MS; Sehgal S; Du Toit S; Yarndley T; Conaglen JV
J Clin Endocrinol Metab; 2016 Sep; 101(9):3251-5. PubMed ID: 27362288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
